ONCOLOGY

Tumor immune surveillance

Aug 6, 2023 by in ONCOLOGY Comments Off on Tumor immune surveillance

Summary of key facts • The concept of tumor immunosurveillance can be traced back to the early 1900s in association with observations that a potentially overwhelming frequency of carcinomas must…

read more

Cancer—avoiding immune detection

Aug 6, 2023 by in ONCOLOGY Comments Off on Cancer—avoiding immune detection

Summary of key facts • The natural history of a human malignancy and its relationship to the host immune system has been described as comprising the “three Es”: elimination, equilibrium,…

read more

Tumor antigenicity and cancer as non-self

Aug 6, 2023 by in ONCOLOGY Comments Off on Tumor antigenicity and cancer as non-self

Summary of key facts • Professor Paul Ehrlich is credited with introducing the concept of cancers as non-self and proposing the concept of tumor immune surveillance in 1909. • Evidence…

read more

Cancer and the science of innate immunity

Aug 6, 2023 by in ONCOLOGY Comments Off on Cancer and the science of innate immunity

Summary of key facts • The innate immune system is the host’s first line of immune defense against challenges of the environment. • The innate immune system response is a…

read more

Development and structure of the lymphoid system

Aug 6, 2023 by in ONCOLOGY Comments Off on Development and structure of the lymphoid system

Summary of key facts • The lymphatic system is a complex, blind-ended vascular tree distinct and separate from the blood circulatory system. • Lymphatics facilitate tissue fluid homeostasis, nutrient uptake,…

read more

(ICD‐O C01, C05.1, 2, C09, C10.0, 2, 3, C11–13)

Dec 15, 2022 by in ONCOLOGY Comments Off on (ICD‐O C01, C05.1, 2, C09, C10.0, 2, 3, C11–13)

PHARYNX (ICD‐O C01, C05.1, 2, C09, C10.0, 2, 3, C11–13) Rules for Classification The classification applies only to carcinomas. There should be histological confirmation of the disease. Anatomical Sites and…

read more

TUMOURS (ICD‐O‐3 C50)

Dec 15, 2022 by in ONCOLOGY Comments Off on TUMOURS (ICD‐O‐3 C50)

BREAST TUMOURS (ICD‐O‐3 C50) Rules for Classification The classification applies only to carcinomas and concerns the male as well as the female breast. There should be histological confirmation of the…

read more
Get Clinical Tree app for offline access